Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 24, 2017

DrugPatentWatch Database Preview

Metoprolol succinate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for metoprolol succinate and what is the scope of metoprolol succinate patent protection?

Metoprolol succinate
is the generic ingredient in two branded drugs marketed by Wockhardt, Dr Reddys Labs Ltd, Actavis Labs Fl Inc, Mylan Pharms Inc, Nesher Pharms, Actavis Elizabeth, Aralez Pharms, Sandoz, and Reddys, and is included in thirteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fifty-eight drug master file entries for metoprolol succinate. Forty suppliers are listed for this compound.

Summary for Generic Name: metoprolol succinate

Drug Master File Entries: see list58
Suppliers / Packagers: see list40
Bulk Api Vendors: see list105
Clinical Trials: see list110
Patent Applications: see list6,456
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:metoprolol succinate at DailyMed

Pharmacology for Ingredient: metoprolol succinate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aralez Pharms
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-002Jan 10, 1992ABRXYesNo► Subscribe► Subscribe
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL076969-001Jul 31, 2006DISCNNoNo► Subscribe► Subscribe
Mylan Pharms Inc
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL202033-001Dec 15, 2011ABRXNoNo► Subscribe► Subscribe
Dr Reddys Labs Ltd
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL090617-002Aug 1, 2012ABRXNoNo► Subscribe► Subscribe
Mylan Pharms Inc
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL202033-004Dec 15, 2011ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus